Validation of an LC-MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsies

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 945-946, Issue , 2014, Pages 171-177

  Md Dom, Zaipul I ^a,b   Noll, Benjamin D ^a   Coller, Janet K ^b   Somogyi, Andrew A ^b   Russ, Graeme R ^c   Hesselink, Dennis A ^d   van Gelder, Teun ^d   Sallustio, Benedetta C ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

LC MS MS; Mycophenolic acid; Tissue MPA concentrations; Transplantation

Indexed keywords

AMINO ACIDS; BIOPSY; ELECTROSPRAY IONIZATION; EXTRACTION; GRAFTS; PATIENT MONITORING; QUALITY CONTROL; TRANSPLANTATION (SURGICAL);

COEFFICIENTS OF VARIATIONS; EXTRACTION EFFICIENCIES; HUMAN KIDNEY TISSUE; LC-MS/MS; LIQUID-LIQUID EXTRACTION; MULTIPLE REACTION MONITORING; MYCOPHENOLIC ACIDS; THERAPEUTIC DRUG MONITORING;

TISSUE;

MYCOPHENOLIC ACID;

ANIMAL TISSUE; ARTICLE; DRUG STRUCTURE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY HOMOGENATE; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; VALIDATION PROCESS;

RATTUS;

LC-MS/MS; MYCOPHENOLIC ACID; TISSUE MPA CONCENTRATIONS; TRANSPLANTATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOPSY; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LIQUID-LIQUID EXTRACTION; MALE; MYCOPHENOLIC ACID; RATS; RATS, WISTAR; TANDEM MASS SPECTROMETRY;

EID: 84890360358     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2013.11.056     Document Type: Article

References (33)

1. Sollinger H.W. Clin. Transplant. 2004, 18:485-492.
2. Shaw L.M., Figurski M., Milone M.C., Trofe J., Bloom R.D. Clin. J. Am. Soc. Nephrol. 2007, 2:1062-1072.
3. van Gelder T., Le Meur Y., Shaw L.M., Oellerich M., DeNofrio D., Holt C., Holt D.W., Kaplan B., Kuypers D., Meiser B., Toenshoff B., Mamelok R.D. Ther. Drug Monit. 2006, 28:145-154.
4. Transplantation 1996, 61:1029-1037. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
5. Mahalati K., Kahan B.D. Ann. Transplant.: Q. Polish Transplant. Soc. 2000, 5:14-23.
6. Mourad M., Malaise J., Chaib Eddour D., De Meyer M., Konig J., Schepers R., Squifflet J.P., Wallemacq P. Clin. Chem. 2001, 47:88-94.
7. Shaw L.M., Korecka M., Venkataramanan R., Goldberg L., Bloom R., Brayman K.L. Am. J. Transplant. 2003, 3:534-542.
8. Borrows R., Chusney G., James A., Stichbury J., Van Tromp J., Cairns T., Griffith M., Hakim N., McLean A., Palmer A., Papalois V., Taube D. Ther. Drug Monit. 2005, 27:442-450.
9. Le Meur Y., Borrows R., Pescovitz M.D., Budde K., Grinyo J., Bloom R., Gaston R., Walker R.G., Kuypers D., van Gelder T., Kiberd B. Transplant. Rev. 2011, 25:58-64.
10. Sandborn W.J., Lawson G.M., Cody T.J., Porayko M.K., Hay J.E., Gores G.J., Steers J.L., Krom R.A., Wiesner R.H. Hepatology 1995, 21:70-76.
11. Capron A., Lerut J., Verbaandert C., Mathys J., Ciccarelli O., Vanbinst R., Roggen F., De Reyck C., Lemaire J., Wallemacq P.E. Ther. Drug Monit. 2007, 29:340-348.
12. Capron A., Lerut J., Latinne D., Rahier J., Haufroid V., Wallemacq P. Transplant Int. 2012, 25:41-47.
13. Sandborn W.J., Lawson G.M., Krom R.A., Wiesner R.H. Hepatology 1992, 15:1086-1091.
14. Hanås E., Tufveson G., Lindgren P.-G., Sjoberg O., Totterman T.H. Clin. Transplant. 1991, 5:107-111.
15. Noll B.D., Coller J.K., Somogyi A.A., Morris R.G., Russ G.R., Hesselink D.A., van Gelder T., Sallustio B.C. Ther. Drug Monit. 2011, 33:688-693.
16. Jemal M. Biomed. Chromatogr. 2000, 14:422-429.
17. Vogeser M., Zachoval R., Spohrer U., Jacob K. Ther. Drug Monit. 2001, 23:722-724.
18. Hesselink D.A., van Hest R.M., Mathot R.A., Bonthuis F., Weimar W., de Bruin R.W., van Gelder T. Am. J. Transplant. 2005, 5:987-994.
19. US Food and Drug Administration 2001, Center for Drug Evaluation and Research, Available: http://www.fda.gov/downloads/Drugs/Guidance/ComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
20. Taylor P.J. Clin. Biochem. 2005, 38:328-334.
21. Noll B.D., Coller J.K., Somogyi A.A., Morris R.G., Russ G.R., Hesselink D.A., van Gelder T., Sallustio B.C. Ther. Drug Monit. 2013, 35:617-623.
22. Bonfiglio R., King R.C., Olah T.V., Merkle K. Rapid Commun. Mass Spectrom. 1999, 13:1175-1185.
23. Solez K., Colvin R.B., Racusen L.C., Haas M., Sis B., Mengel M., Halloran P.F., Baldwin W., Banfi G., Collins A.B., Cosio F., David D.S., Drachenberg C., Einecke G., Fogo A.B., Gibson I.W., Glotz D., Iskandar S.S., Kraus E., Lerut E., Mannon R.B., Mihatsch M., Nankivell B.J., Nickeleit V., Papadimitriou J.C., Randhawa P., Regele H., Renaudin K., Roberts I., Seron D., Smith R.N., Valente M. Am. J. Transplant. 2008, 8:753-760.
24. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:3019-3030.
25. Westley I.S., Sallustio B.C., Morris R.G. Clin. Biochem. 2005, 38:824-829.
26. Srivatsan V., Dasgupta A.K., Kale P., Verma R., Joshi P., Soni D., Patel M., Soni G., Patel J., Modi H. J. Chromatogr. A 2004, 1031:259-264.
27. Bahrami G., Mohammadi B. Clin. Chim. Acta 2006, 370:185-190.
28. Wiwattanawongsa K., Heinzen E.L., Kemp D.C., Dupuis R.E., Smith P.C. J. Chromatogr. B: Biomed. Sci. Appl. 2001, 763:35-45.
29. Khoschsorur G., Erwa W. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2004, 799:355-360.
30. Buchwald A., Winkler K., Epting T. BMC Clin. Pharmacol. 2012, 12:2.
31. Figurski M.J., Korecka M., Fields L., Waligorska T., Shaw L.M. Ther. Drug Monit. 2009, 31:717-726.
32. Kuhn J., Prante C., Kleesiek K., Gotting C. Clin. Biochem. 2009, 42:83-90.
33. Van Eeckhaut A., Lanckmans K., Sarre S., Smolders I., Michotte Y. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2009, 877:2198-2207.